Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study
Abstract Background Whether long-chain n–3 PUFAs of marine origin have an anti-atherogenic effect in the general population has hardly been studied. In this population-based study, we hypothesized that fatty fish and fish oil intake protect against development of novel atherosclerotic plaques and is...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-05-01
|
Series: | Nutrition Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12937-018-0364-8 |
_version_ | 1817993514542170112 |
---|---|
author | Stein Harald Johnsen Bjarne K. Jacobsen Sigrid K. Brækkan John-Bjarne Hansen Ellisiv B. Mathiesen |
author_facet | Stein Harald Johnsen Bjarne K. Jacobsen Sigrid K. Brækkan John-Bjarne Hansen Ellisiv B. Mathiesen |
author_sort | Stein Harald Johnsen |
collection | DOAJ |
description | Abstract Background Whether long-chain n–3 PUFAs of marine origin have an anti-atherogenic effect in the general population has hardly been studied. In this population-based study, we hypothesized that fatty fish and fish oil intake protect against development of novel atherosclerotic plaques and is associated with reduced plaque size. Methods We obtained questionnaire-based information on fish consumption and carotid ultrasonography from 3900 persons aged 45–74 years. The questionnaires were validated by measuring serum concentrations of PUFAs and triglycerides in a subgroup. At follow-up seven years later, 2983 (76%) went through a second ultrasound scanning. Logistic regression and general linear models were used to analyze the outcome (plaque presence and plaque area) as a function of fish consumption, including analyses stratified on fish oil supplements. Results At baseline, lean fish intake < 1 time/week vs. 1–1.9 times/week was associated with risk of plaque (OR 1.34, 95% CI 1.03–1.76). Fatty fish intake and use of fish oil supplements were not statistically significantly associated with atherosclerosis at baseline. In persons without plaque at baseline, total fish consumption ≥3 times/week vs. 1–1.9 times/week was associated with risk of novel plaque (OR 1.32, 95% CI 1.01–1.73) and larger plaque area (1.76 mm2 vs. 1.46 mm2, p = 0.02) at follow-up. Adjustments for use of fish oil supplements had no impact on the associations, and no interactions were seen between total, fatty or lean fish consumption and fish oil intake. Conclusions We found no protective effect of fatty fish eating or fish oil supplements on atherosclerotic plaque formation or plaque area in a general population. Lean fish consumption was associated with a reduced risk for plaque in cross-sectional analysis, suggesting that the beneficial effects of fish consumption on atherosclerosis may be mediated through other mechanisms than n-3 PUFAs. |
first_indexed | 2024-04-14T01:39:57Z |
format | Article |
id | doaj.art-f2e82fd8a13f4027812839147db33e1c |
institution | Directory Open Access Journal |
issn | 1475-2891 |
language | English |
last_indexed | 2024-04-14T01:39:57Z |
publishDate | 2018-05-01 |
publisher | BMC |
record_format | Article |
series | Nutrition Journal |
spelling | doaj.art-f2e82fd8a13f4027812839147db33e1c2022-12-22T02:19:48ZengBMCNutrition Journal1475-28912018-05-011711910.1186/s12937-018-0364-8Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø studyStein Harald Johnsen0Bjarne K. Jacobsen1Sigrid K. Brækkan2John-Bjarne Hansen3Ellisiv B. Mathiesen4Department of Neurology, University Hospital of North NorwayDepartment of Community Medicine, UiT The Arctic University of NorwayK. G. Jebsen TREC - Thrombosis Research and Expertise Center, Department of Clinical Medicine, UiT The Arctic University of NorwayK. G. Jebsen TREC - Thrombosis Research and Expertise Center, Department of Clinical Medicine, UiT The Arctic University of NorwayDepartment of Neurology, University Hospital of North NorwayAbstract Background Whether long-chain n–3 PUFAs of marine origin have an anti-atherogenic effect in the general population has hardly been studied. In this population-based study, we hypothesized that fatty fish and fish oil intake protect against development of novel atherosclerotic plaques and is associated with reduced plaque size. Methods We obtained questionnaire-based information on fish consumption and carotid ultrasonography from 3900 persons aged 45–74 years. The questionnaires were validated by measuring serum concentrations of PUFAs and triglycerides in a subgroup. At follow-up seven years later, 2983 (76%) went through a second ultrasound scanning. Logistic regression and general linear models were used to analyze the outcome (plaque presence and plaque area) as a function of fish consumption, including analyses stratified on fish oil supplements. Results At baseline, lean fish intake < 1 time/week vs. 1–1.9 times/week was associated with risk of plaque (OR 1.34, 95% CI 1.03–1.76). Fatty fish intake and use of fish oil supplements were not statistically significantly associated with atherosclerosis at baseline. In persons without plaque at baseline, total fish consumption ≥3 times/week vs. 1–1.9 times/week was associated with risk of novel plaque (OR 1.32, 95% CI 1.01–1.73) and larger plaque area (1.76 mm2 vs. 1.46 mm2, p = 0.02) at follow-up. Adjustments for use of fish oil supplements had no impact on the associations, and no interactions were seen between total, fatty or lean fish consumption and fish oil intake. Conclusions We found no protective effect of fatty fish eating or fish oil supplements on atherosclerotic plaque formation or plaque area in a general population. Lean fish consumption was associated with a reduced risk for plaque in cross-sectional analysis, suggesting that the beneficial effects of fish consumption on atherosclerosis may be mediated through other mechanisms than n-3 PUFAs.http://link.springer.com/article/10.1186/s12937-018-0364-8AtherosclerosisFish consumptionPUFAsCarotid ultrasonographyFish oil |
spellingShingle | Stein Harald Johnsen Bjarne K. Jacobsen Sigrid K. Brækkan John-Bjarne Hansen Ellisiv B. Mathiesen Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study Nutrition Journal Atherosclerosis Fish consumption PUFAs Carotid ultrasonography Fish oil |
title | Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study |
title_full | Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study |
title_fullStr | Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study |
title_full_unstemmed | Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study |
title_short | Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study |
title_sort | fish consumption fish oil supplements and risk of atherosclerosis in the tromso study |
topic | Atherosclerosis Fish consumption PUFAs Carotid ultrasonography Fish oil |
url | http://link.springer.com/article/10.1186/s12937-018-0364-8 |
work_keys_str_mv | AT steinharaldjohnsen fishconsumptionfishoilsupplementsandriskofatherosclerosisinthetromsøstudy AT bjarnekjacobsen fishconsumptionfishoilsupplementsandriskofatherosclerosisinthetromsøstudy AT sigridkbrækkan fishconsumptionfishoilsupplementsandriskofatherosclerosisinthetromsøstudy AT johnbjarnehansen fishconsumptionfishoilsupplementsandriskofatherosclerosisinthetromsøstudy AT ellisivbmathiesen fishconsumptionfishoilsupplementsandriskofatherosclerosisinthetromsøstudy |